Inventor
LAZARSKI KIEL
US24 patents
⚠️ This page may combine multiple inventors who share the name “LAZARSKI KIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
C4 THERAPEUTICS INC
12 patentsUS11185592B2Nov 30, 2021
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC20 citations93
US10660968B2May 26, 2020
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC32 citations93
US10849982B2Dec 1, 2020
C3-carbon linked glutarimide degronimers for target protein degradation
C4 THERAPEUTICS INC43 citations92
US11524949B2Dec 13, 2022
Degraders and Degrons for targeted protein degradation
C4 THERAPEUTICS INC7 citations85
US12371442B2Jul 29, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC1 citations74
US12048747B2Jul 30, 2024
Substituted piperidine Degronimers for Target Protein degradation
C4 THERAPEUTICS INC4 citations74
US11992531B2May 28, 2024
C3-carbon linked glutarimide degronimers for target protein degradation
C4 THERAPEUTICS INC3 citations73
US11673902B2Jun 13, 2023
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC3 citations72
US12570626B2Mar 10, 2026
Degraders and degrons for targeted protein degradation
C4 THERAPEUTICS INC0 citations62
US12486290B2Dec 2, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC0 citations62
US12048748B2Jul 30, 2024
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC1 citations62
US12421220B2Sep 23, 2025
Bicyclic-substituted glutarimide cereblon binders
C4 THERAPEUTICS INC0 citations47
BAYER AG
6 patentsUS10981932B2Apr 20, 2021
Macrocyclic indole derivatives
BAYER AG9 citations83
US11492358B1Nov 8, 2022
Macrocyclic indole derivatives
BAYER AG3 citations71
US11478451B1Oct 25, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11447504B2Sep 20, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11440923B2Sep 13, 2022
Substituted macrocyclic indole derivatives
BAYER AG3 citations71
US11891404B2Feb 6, 2024
Substituted macrocyclic indole derivatives
BAYER AG1 citations61
HOFFMANN LA ROCHE
3 patentsUS12209091B2Jan 28, 2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
HOFFMANN LA ROCHE7 citations85
US11708354B2Jul 25, 2023
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
HOFFMANN LA ROCHE3 citations72
US10882848B2Jan 5, 2021
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
HOFFMANN LA ROCHE3 citations72